Thérèse Aurran‐Schleinitz

Acalabrutinib monotherapy in patients with Waldenström macroglobulinemia: a single-arm, multicentre, phase 2 study

Roger G. Owen, Helen O. McCarthy, Simon Rule et al. · The Lancet Haematology · 2019 · 164 citations · Full text

Medicine, Hematology, Pharmacology +4

SHC and SHIP phosphorylation and interaction in response to activation of the FLT3 receptor

Sylvie Marchetto, Emmanuel Fournier, Nathalie Beslu et al. · Leukemia · 1999 · 74 citations

Life Sciences, Biochemistry, Molecular Biology +9

Primary B-CLL Resistance to NK Cell Cytotoxicity can be Overcome In Vitro and In Vivo by Priming NK Cells and Monoclonal Antibody Therapy

Caroline Veuillen, Thérèse Aurran‐Schleinitz, Rémy Castellano et al. · Journal of Clinical Immunology · 2012 · 52 citations

Life Sciences, Cancer Biology, Immunology +16

First‐line treatment of double‐hit and triple‐hit lymphomas: Survival and tolerance data from a retrospective multicenter French study

Marie‐Charlotte Laude, Laure Lebras, Pierre Sesques et al. · American Journal of Hematology · 2020 · 50 citations · Full text

Medicine, Oncology, Chemotherapy +14

Management of central nervous system involvement in chronic lymphocytic leukaemia: a retrospective cohort of 30 patients

Anne Wanquet, Rudy Birsen, Charlotte Bonnet et al. · British Journal of Haematology · 2016 · 47 citations · Full text

Medicine, Hematology, Oncology +14